| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |